We are live on ! Find out more
TLP

Tri Locum Partners Portfolio holdings

AUM $713M
1-Year Est. Return 68.92%
This Fund
S&P 500
This Quarter Est. Return
+14.79%
1 Year Est. Return
+68.92%
3 Year Est. Return
+377.81%
5 Year Est. Return
+1,289.15%
10 Year Est. Return
–
AUM
$219M
AUM Growth
-$94M
Cap. Flow
-$113M
Cap. Flow %
-51.44%
Top 10 Hldgs %
66.53%
Holding
66
New
5
Increased
5
Reduced
14
Closed
42

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$11.3M
2
ASND icon
Ascendis Pharma A/S
ASND
+$9.93M
3
LEGN icon
Legend Biotech
LEGN
+$6.48M
4
ARGX icon
argenx
ARGX
+$4.58M
5
ABBV icon
AbbVie
ABBV
+$3.39M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.9M
2
DXCM icon
DexCom
DXCM
+$24.9M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$19.3M
4
WST icon
West Pharmaceutical
WST
+$8.42M
5
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$8.04M

Sector Composition

Rank Sector Weight
1 Healthcare 93.12%
2 Consumer Staples 0%
3 Energy 0%
4 Financials 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SDGR icon
51
Schrodinger
SDGR
$1.23B
– –
-8,316
Closed -$235K
SLRN
52
DELISTED
ACELYRIN
SLRN
– –
-155,573
Closed -$1.58M
SPY icon
53
State Street SPDR S&P 500 ETF Trust
SPY
$819B
– –
-45,208
Closed -$19.3M
TEL icon
54
TE Connectivity
TEL
$63.2B
– –
-1,732
Closed -$214K
TVTX icon
55
Travere Therapeutics
TVTX
$5.84B
– –
-251,702
Closed -$2.25M
UAA icon
56
Under Armour
UAA
$2.88B
– –
-12,904
Closed -$88.4K
UPS icon
57
United Parcel Service
UPS
$91.5B
– –
-1,423
Closed -$222K
VERA icon
58
Vera Therapeutics
VERA
$2.18B
– –
-43,438
Closed -$596K
WST icon
59
West Pharmaceutical
WST
$24.7B
– –
-22,454
Closed -$8.42M
XFOR icon
60
X4 Pharmaceuticals
XFOR
$391M
– –
-208,250
Closed -$6.81M
YUM icon
61
Yum! Brands
YUM
$41.6B
– –
-1,751
Closed -$219K
SWN
62
DELISTED
Southwestern Energy Company
SWN
– –
-13,693
Closed -$88.3K
SILK
63
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
– –
-536,392
Closed -$8.04M
MORF
64
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-36,606
Closed -$839K
ALPN
65
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-314,029
Closed -$3.6M
IMGN
66
DELISTED
Immunogen Inc
IMGN
– –
-369,912
Closed -$5.87M
1 2
3

Similar funds

DCM
Defilade Capital Management Emeryville, California $712M AUM
AMPWP
Alvarez & Marsal Private Wealth Partners West Palm Beach, Florida $712M AUM
DCM
Dimension Capital Management Coral Gables, Florida $713M AUM 18.57% 1-Year Est. Return
IWP
Insight Wealth Partners Plano, Texas $713M AUM 16.55% 1-Year Est. Return
PCS
Personal CFO Solutions Chester, New Jersey $712M AUM 25.3% 1-Year Est. Return
ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $714M AUM 35.97% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
ECM
EagleClaw Capital Management Boston, Massachusetts $714M AUM 24.24% 1-Year Est. Return

Tri Locum Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Tri Locum Partners held 66 positions worth $219M, down 30% from $313M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Tri Locum Partners withdrew a net $113M in Q4 2023, closing 42 positions and reducing 14 holdings. Its most notable exit was Amgen, an estimated $28.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 93% a quarter earlier, followed by Consumer Staples and Energy.

Against the trend, Tri Locum Partners opened a new position in Biogen worth $11.9M.

  • Tri Locum Partners's largest Q4 2023 buy was Biogen: 45,814 shares worth $11.9M.
  • Tri Locum Partners added most to argenx in Q4 2023, an estimated $4.58M increase.
  • Tri Locum Partners's biggest Q4 2023 reduction was Teva Pharmaceuticals, cutting an estimated $7.83M.
  • Tri Locum Partners fully exited Amgen in Q4 2023, selling an estimated $28.9M.
  • Tri Locum Partners's ten largest holdings make up 67% of its $219M portfolio in Q4 2023.
  • Tri Locum Partners opened 5 new positions and closed 42 in Q4 2023.
  • Tri Locum Partners's portfolio value fell 30% quarter-over-quarter to $219M.

Based on Tri Locum Partners's 13F filing for Q4 2023, filed 14 Feb 2024.